- Home
- SMXT vs SERA Comparison
SMXT vs SERA Comparison
Compare SMXT & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMXT
- SERA
- Stock Information
- Founded
- SMXT 2008
- SERA 2008
- Country
- SMXT United States
- SERA United States
- Employees
- SMXT N/A
- SERA 64
- Industry
- SMXT
- SERA Precision Instruments
- Sector
- SMXT
- SERA Health Care
- Exchange
- SMXT NYSE
- SERA Nasdaq
- Market Cap
- SMXT 54.5M
- SERA 70.4M
- IPO Year
- SMXT 2024
- SERA 2021
- Fundamental
- Price
- SMXT $1.08
- SERA $2.70
- Analyst Decision
- SMXT
- SERA
- Analyst Count
- SMXT 0
- SERA 0
- Target Price
- SMXT N/A
- SERA N/A
- AVG Volume (30 Days)
- SMXT 245.3K
- SERA 803.6K
- Earning Date
- SMXT 08-13-2025
- SERA 08-06-2025
- Dividend Yield
- SMXT N/A
- SERA N/A
- EPS Growth
- SMXT N/A
- SERA N/A
- EPS
- SMXT N/A
- SERA N/A
- Revenue
- SMXT $24,150,276.00
- SERA $115,000.00
- Revenue This Year
- SMXT N/A
- SERA $390.13
- Revenue Next Year
- SMXT N/A
- SERA $440.54
- P/E Ratio
- SMXT N/A
- SERA N/A
- Revenue Growth
- SMXT N/A
- SERA N/A
- 52 Week Low
- SMXT $0.60
- SERA $1.37
- 52 Week High
- SMXT $4.68
- SERA $9.13
- Technical
- Relative Strength Index (RSI)
- SMXT N/A
- SERA 51.60
- Support Level
- SMXT N/A
- SERA $1.82
- Resistance Level
- SMXT N/A
- SERA $2.08
- Average True Range (ATR)
- SMXT 0.00
- SERA 0.18
- MACD
- SMXT 0.00
- SERA 0.08
- Stochastic Oscillator
- SMXT 0.00
- SERA 85.92
About SMXT SOLARMAX TECHNOLOGY INC
SolarMax Technology Inc is an integrated solar and renewable energy company. It operates in two segments namely the United States and China. The United States business includes the sale and installation of photovoltaic and battery backup systems. China operations consist of operating and maintaining solar farm projects and identifying and procuring solar farm projects for resale to third parties. Some of its products are LG Solar Panels, QCELL Solar Panels, Panasonic Solar Panels, and others. The company generates a majority of its revenue from the Solar energy systems.
About SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.